In her poster, “Development of an electrochemical single nucleotide polymorphism (SNP) detection platform for cardiovascular point-of-care diagnostics”, Afraa Razouk showcased results from developing a genomic platform for SNP detection, which directly contributes to PoCCardio’s point-of-care platform for personalised cardiovascular risk assessment.

Afraa Razouk is a PhD Student in Nanoscience, Materials, and Chemical Engineering at Interfibio, a group within the Department of Chemical Engineering at Universitat Rovira i Virgili

Based on finger-prick blood samples, the electrochemical platform is used for multiplexed detection of clinically relevant single nucleotide polymorphisms (SNPs). It includes the optimisation of allele-specific primers using the Amplification Refractory Mutation System (ARMS) in solid-phase recombinase polymerase amplification (RPA) on gold electrodes, and the incorporation of ferrocene-labelled nucleotides (Fc-dNTPs) for electrochemical signal generation.

These developments establish key technological components for integrating multiple genetic targets into a single, portable and cost-effective diagnostic device, ultimately supporting personalised cardiovascular risk stratification and informed therapeutic decision-making.

Afraa Razouk received the award at the Transfrontier Meeting, an annual scientific conference bringing together French and Spanish researchers in sensors, biosensors and analytical chemistry. This year, the event took place in Perpignan, France, from 17-18 September 2026.